Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $3.1 million.

  • Pyxis Oncology's Share-based Compensation rose 308.62% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year change of. This contributed to the annual value of $12.9 million for FY2024, which is 2361.03% down from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Share-based Compensation is $3.1 million, which was up 308.62% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Share-based Compensation ranged from a high of $4.3 million in Q1 2024 and a low of $2.8 million during Q4 2024